WHO ICTRP trial
An Observational follow-up study to Protocol 018
EUCTR2013-001526-26-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2013-001526-26-IT |
|---|---|
| Public title | An Observational follow-up study to Protocol 018 |
| Scientific title | An Observational Follow-Up Study for: A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated With Vitamin D and Calcium (Protocol 018) - An Observational follow-up… |
| Primary sponsor | Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Serbia;United States;Philippines;Hong Kong;Estonia;Taiwan;Spain;Ukraine;Lebanon;Russian Federation;Chile;Colombia;Switzerland;Italy;India;France;Denmark;Peru;Australia;South Africa;Latvia;China;Korea… |
| Conditions | Osteoporosis MedDRA version: 16.0 Level: PT Classification code 10031282 Term: Osteoporosis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders ;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05] |
| Interventions | Product Code: MK-0822 Pharmaceutical Form: Tablet CAS Number: 603139-19-1 Current Sponsor code: MK-0822 Other descriptive name: Odanacatib Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 0- |
| Registration date | Sep 8, 2013 |
| Target size | 6000 |
| Secondary IDs | 083 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: